The Evidence Based Rheumatology Podcast

← The Evidence Based Rheumatology Podcast15. Juni · 14 Min.

E136: Secukinumab in PMR (REPLENISH)

E136: Secukinumab in PMR (REPLENISH)15. Juni14 Min.

Big trial this week in the NEJM investigating the IL17 inhibitor secukinumab in PMR. Well worth a read, I would bet on FDA approval in the near future. Some interesting tidbits and of course a weird safety thing we now have to grapple with.

Be sure to go to boardsbank.com! Free rheumatology board review, >1000 questions!

Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2602567